Abbott Laboratories (ABT): stock score 36/100

Abbott Laboratories (ABT) scores 36 out of 100 (below average among 99 US stocks) on trend, stability, fundamentals, market backdrop and news tone. Every calculation step shown. Educational, not advice.

ABT scores 36.1 out of 100 (below average), down 0.1 points from last week. Its news tone adds the most (+3.3 points: average FinBERT sentiment +0.161 over 34 articles). Its stability weighs on it most (-7.3 points: forecast 22.7% vs normal 20.5%). Our research found no proven record of these factors predicting returns.

How the score is built

Trend: 29/100 (-4.1 points)

1. Price is +2.3% vs its 100-day average → higher than 47% of the comparison group → 47
2. 12-1 month momentum -17.3% → higher than 12% of the comparison group → 12
3. Average of the two → trend score 29.3

Tested in our research: the trend rule did not hold up out of sample.

Stability: 14/100 (-7.3 points)

1. Forecast 22.7% vs normal 20.5% → ratio 1.11
2. Ratio is higher than 86% of the comparison group → 100 minus 86 → stability 13.6 (bigger expected swings than usual → lower stability)

A machine-learning volatility model beat HAR for the S&P 500 (p = 0.04); not yet tested on single stocks. This component uses HAR.

Fundamentals: 20/100 (-6.0 points)

1. Revenue growth vs a year earlier: +7.8% → higher than 51% of the comparison group → 51
2. Operating-margin change vs a year earlier: -4.3 pp → higher than 7% of the comparison group → 7
3. Change in leverage (1 - equity/assets) vs a year earlier: +12.8 pp → higher than 3% of the comparison group (lower is better) → 3
4. Average of available items → fundamentals score 20.1

Not yet tested in our research.

Market backdrop: 51/100 (+0.2 points)

1. VIX in its 5-year range: 60 after inverting (lower VIX → higher)
2. Breadth vs its 5-year range → 45
3. Credit trend vs its 5-year range → 15
4. Yield curve vs its 5-year range → 83
5. Average → backdrop score 50.8 (same for every stock)

Tested in our research: cross-asset indicators did not improve forecasts.

News tone: 66/100 (+3.3 points)

1. Average FinBERT sentiment +0.161 over 34 articles; shrunk towards 0 for few articles → tone +0.140
2. Tone vs this stock's own past year → news score 66.5

Tested in our research: news sentiment made predictions slightly worse.

ABT score history (weekly)

Health care stocks compared

• ABBV: 62/100
• AMGN: 62/100
• LLY: 60/100
• MMM: 59/100
• BIIB: 58/100
• GILD: 54/100
• PFE: 50/100
• BMY: 50/100
• UNH: 49/100
• MDT: 48/100
• MRK: 37/100
• ABT: 36/100
• JNJ: 36/100

Questions

What is Abbott Laboratories's (ABT) Quantooo score today?

ABT scores 36 out of 100 on 2026-10-22, below average among 99 US stocks. It ranks 87th of 99 overall and 12th of 13 in Health care. It was 36 a week earlier.

What raises and lowers ABT's score?

News tone adds the most (66/100, +3.3 points) and stability weighs on it most (14/100, -7.3 points). The score is 50 plus each part's weighted distance from 50.

Is ABT stock volatile right now?

Our volatility model (HAR) expects annualised swings of 22.7% over the next 20 trading days, against a normal level of 20.5% for ABT: bumpier than usual for this stock. Its stability score is 14/100 compared with the other 99 US stocks.

How are Abbott Laboratories's fundamentals changing?

Revenue growth vs a year earlier: +7.8%; Operating-margin change vs a year earlier: -4.3 pp; Change in leverage (1 - equity/assets) vs a year earlier: +12.8 pp. Fundamentals score: 20/100. From the 10-Q filed 2026-04-29 (period to 2026-03-31).

Does the score predict ABT's share price?

No. The score describes the stock's recent data; it is not a forecast of the share price. Our own tests found no reliable ability to rank stocks by future returns, and every test, including the failures, is published. Educational, not investment advice.

Sector: Health care. Data as of 2026-10-22. Scores describe data; they are not recommendations or predictions. Educational, not investment advice.